DONISI, CLELIA
 Distribuzione geografica
Continente #
EU - Europa 20.247
NA - Nord America 1.759
AS - Asia 1.436
SA - Sud America 207
AF - Africa 40
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 23.694
Nazione #
IT - Italia 19.684
US - Stati Uniti d'America 1.688
SG - Singapore 571
CN - Cina 408
BR - Brasile 156
VN - Vietnam 155
SE - Svezia 145
DE - Germania 81
FR - Francia 66
FI - Finlandia 63
IN - India 62
GB - Regno Unito 59
HK - Hong Kong 54
CA - Canada 42
NL - Olanda 41
BD - Bangladesh 31
KR - Corea 31
MX - Messico 20
PL - Polonia 20
IQ - Iraq 16
ZA - Sudafrica 16
AT - Austria 15
IE - Irlanda 13
AR - Argentina 12
EC - Ecuador 11
ES - Italia 11
JP - Giappone 11
SA - Arabia Saudita 11
CO - Colombia 10
TR - Turchia 10
PK - Pakistan 9
VE - Venezuela 9
BE - Belgio 8
ID - Indonesia 8
PH - Filippine 8
AE - Emirati Arabi Uniti 7
IR - Iran 7
UZ - Uzbekistan 7
IL - Israele 6
GR - Grecia 5
LT - Lituania 5
RU - Federazione Russa 5
TH - Thailandia 5
AL - Albania 4
AU - Australia 4
CZ - Repubblica Ceca 4
KG - Kirghizistan 4
MA - Marocco 4
PY - Paraguay 4
DZ - Algeria 3
KE - Kenya 3
PT - Portogallo 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AZ - Azerbaigian 2
CH - Svizzera 2
CL - Cile 2
GA - Gabon 2
JM - Giamaica 2
LU - Lussemburgo 2
LV - Lettonia 2
NP - Nepal 2
OM - Oman 2
RS - Serbia 2
SC - Seychelles 2
UA - Ucraina 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BJ - Benin 1
BO - Bolivia 1
CY - Cipro 1
DM - Dominica 1
EG - Egitto 1
ET - Etiopia 1
HN - Honduras 1
HR - Croazia 1
KZ - Kazakistan 1
LB - Libano 1
LY - Libia 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
UG - Uganda 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 23.694
Città #
Cagliari 18.425
Uta 987
Singapore 349
Ashburn 274
Dallas 243
San Jose 177
Boardman 94
Beijing 76
Nyköping 74
Chandler 66
Los Angeles 65
New York 57
Ho Chi Minh City 51
Hong Kong 48
Helsinki 45
The Dalles 43
Fairfield 42
Hefei 40
Rome 37
Hanoi 36
Florence 35
Shanghai 35
Santa Clara 34
Council Bluffs 33
Orem 31
Seoul 30
Munich 27
Amsterdam 26
Guangzhou 22
Lauterbourg 22
Seattle 22
Boston 20
Houston 19
Montreal 18
Redondo Beach 18
Scandicci 18
São Paulo 18
Frankfurt am Main 17
Chicago 16
Nuremberg 16
Buffalo 15
Chennai 15
Pune 15
San Diego 14
Warsaw 14
Wilmington 14
Milan 13
Woodbridge 13
Cambridge 12
Shenzhen 12
Toronto 12
Dublin 11
Denver 10
London 10
Düsseldorf 9
Lappeenranta 9
Stockholm 9
Haiphong 8
Johannesburg 8
Mexico City 8
Turku 8
Manchester 7
Paris 7
Tashkent 7
Hangzhou 6
Poplar 6
Riyadh 6
Tokyo 6
Vienna 6
Atlanta 5
Bexley 5
Brooklyn 5
Forlì 5
Menlo Park 5
Naples 5
Phoenix 5
Rio de Janeiro 5
Roubaix 5
San Francisco 5
Sassari 5
Selargius 5
Tianjin 5
Turin 5
Zhengzhou 5
Belo Horizonte 4
Bishkek 4
Brussels 4
Campinas 4
Caracas 4
Charlotte 4
Curitiba 4
Da Nang 4
Dong Ket 4
Dubai 4
Guayaquil 4
Jeddah 4
La Maddalena 4
Manila 4
Medellín 4
Mumbai 4
Totale 22.135
Nome #
Molecular-biology-driven treatment for metastatic colorectal cancer 2.771
New therapeutic targets in pancreatic cancer 1.640
Immunotherapy and Cancer: The Multi-Omics Perspective 1.610
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment 1.361
Molecular-driven treatment for biliary tract cancer: the promising turning point 1.223
CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors 1.080
Neoadjuvant chemo-radiotherapy response in patients affected by mismatch repair deficient (dMMR) locally advanced rectal cancer 991
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients 962
Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast? 939
Corrigendum: Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients 776
The Difficult Task of Diagnosing Depression in Elderly People with Cancer: A Systematic Review 756
Effect of Cancer-Related Cachexia and Associated Changes in Nutritional Status, Inflammatory Status, and Muscle Mass on Immunotherapy Efficacy and Survival in Patients with Advanced Non-Small Cell Lung Cancer 749
Circulating tumour DNA in gastrointestinal cancer in clinical practice: Just a dream or maybe not? 747
Uncovering key targets of success for immunotherapy in pancreatic cancer 725
Next-Generation Sequencing Whole-Genome Analysis for Targeted Treatment Approach of Metastatic Bartholin Gland Adenocarcinoma: An Emblematic Case Report and Review of the Literature 705
Mismatch Repair system protein deficiency as a resistance factor for locally advanced rectal adenocarcinoma patients receiving neoadjuvant chemo-radiotherapy 658
BRCA-mutant pancreatic ductal adenocarcinoma 620
Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional Imaging 599
Immune Checkpoint Inhibitors in the Treatment of HCC 592
Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment 590
EGFR-Mutated Non-Small Cell Lung Cancer and Resistance to Immunotherapy: Role of the Tumor Microenvironment 575
Understanding the user's point of view: when the doctor gets sick with cancer and seeks help 479
Emerging treatment evolutions and integrated molecular characteristics of biliary tract cancers 450
Clinical score for colorectal cancer patients with lung-limited metastases undergoing surgical resection: Meta-Lung Score 337
Mismatch repair proteins (MMR) expression as predictive factor in locally advanced rectal cancer 210
Early taxane exposure and neurotoxicity in breast cancer patients 207
Thyroid dysfunction and immune checkpoint inhibitors: Effect on survival in elderly patients 203
Early-onset colorectal cancer patients exhibit a distinct molecular fingerprint: insights from a large-scale NGS study of 1209 patients 193
Overall survival and progression-free survival in metastatic colorectal cancer patients with concomitant RAS and BRAF mutations: a single center experience 170
The impact of surgical resection in early onset colorectal cancer patients with liver limited disease 120
Clinical characteristics and outcomes in patients with early-onset locally advanced rectal cancer 120
Exercise Prescription in Cardio-Oncology 118
Clinical and molecular features of early-onset metastatic pancreatic cancer and their impact on therapeutic sequences: A multicenter study 115
Influence of levothyroxine concomitant treatment on treatment responses and outcomes in patients with metastatic colorectal adenocarcinoma 108
The correlation between L1CAM expression and outcomes in patients with metastatic colorectal cancer treated with first-line chemotherapy 106
The interconnection between cellular metabolism and lymphocyte activation as a prognostic factor in patients affected by metastatic pancreatic ductal adenocarcinoma treated with gemcitabine and nab-paclitaxel as first line 102
Lymphocyte to monocyte ratio in metastatic pancreatic ductal adenocarcinoma as a prognostic factor and its potential role in identifying a subset of patients with a favorable response to therapy 100
Totale 23.807
Categoria #
all - tutte 36.380
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.380


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021151 0 0 0 0 0 0 0 0 0 0 76 75
2021/20221.168 69 63 4 29 60 100 61 89 77 116 228 272
2022/20233.703 325 526 339 242 270 296 202 311 297 407 314 174
2023/20243.429 159 117 113 184 273 553 549 245 243 239 368 386
2024/20259.999 2.859 3.319 854 923 453 645 423 58 99 119 76 171
2025/20263.782 297 243 400 345 300 278 813 384 257 351 114 0
Totale 23.807